A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study
<p><strong>Background:</strong><br> Myelofibrosis (MF) is a blood cancer associated with splenomegaly, blood count abnormalities, reduced life expectancy and high prevalence of disease-associated symptoms. Current treatment options for MF are diverse, with limited data on man...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
SAGE Publications
2022
|